Efficacy of methylprednisolone therapy for the injured rat spinal cord

Journal of Neuroscience Research

Volumn 68, Issue 1, 2002, Pages 7-18

  Rabchevsky, Alexander G ^a   Fugaccia, Isabella ^a   Sullivan, Patrick G ^b   Blades, Deborah A ^a   Scheff, Stephen W ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Pharmacology; Rat; Spinal cord injury; Stereology; Steroids; Tissue sparing; Treatment

Indexed keywords

GLUCOCORTICOID; METHYLPREDNISOLONE SODIUM SUCCINATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GRAY MATTER; LOCOMOTION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY; STANDARD; STEREOMETRY; WHITE MATTER;

ANIMALS; BEHAVIOR, ANIMAL; CONTUSIONS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; METHYLPREDNISOLONE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; TIME FACTORS;

EID: 0036212885     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10187     Document Type: Article

References (60)

1. + and water content in experimental spinal injury
2. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury
3. Synergistic effect of basic fibroblast growth factor and methylprednisolone on neurological function after experimental spinal cord injury
4. Pathology of experimental spinal cord trauma. The necrotic lesion as a function of vascular injury
5. Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat
6. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weightdrop device vs. transection
7. Modeling of acute spinal cord injury in the rat: Neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673
8. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study
9. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-Year follow-up data. Results of the second National Acute Spinal Cord Injury Study
10. Administration of methylprednisolone for 24 or 48 hr or tirilazad mesylate for 48 hr in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study
11. Involvement of lipid peroxidation in CNS injury
12. Threedimensional computer-assisted analysis of graded contusion lesions in the spinal cord of the rat
13. Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: Transcriptional regulation of inflammatory and neurotrophic genes
14. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats
15. Lipid peroxidation inhibition in spinal cord injury: Cyclosporin-A vs. methylprednisolone
16. Quantitative MRI of spinal cord injury in a rat model
17. Characterization of an experimental spinal cord injury model using waveform and morphometric analysis
18. Effect of the 21-aminosteroid U74006F and methylprednisolone on motor function recovery and edema after spinal cord compression in rats
19. Initial stabilization and medical management of acute spinal cord injury
20. Experimental studies on spinal cord injuries in the last 15 years
21. GM-1 ganglioside and motor recovery following human spinal cord injury
22. Lipid antioxidants in acute central nervous system injury
23. +)-ATPase activity. Dose-response analysis during first hour after contusion injury in the cat
24. Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury
25. Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats
26. Methylprednisolone for acute spinal cord injury: An inappropriate standard of care
27. Methylprednisolone: Therapeutic time window in experimental spinal cord injury in rats
28. Animal models of spinal cord contusion injuries
29. Effect of methylprednisolone, tirilazad mesylate and vitamin E on lipid peroxidation after experimental spinal cord injury
30. Effect of a single huge dose of methylprednisolone on blood flow, evoked potentials, and histology after acute spinal cord injury in the rat
31. Experimental spinal cord contusion injury: Comparison of different outcome parameters
32. Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat
33. Methylprednisolone reduces excitatory amino acid release following experimental spinal cord injury
34. Neuronal and glial apoptosis after traumatic spinal cord injury
35. Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: A potential new anti-inflammatory treatment
36. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord
37. Application of the Cavalieri principle and vertical sections method to lung: Estimation of volume and pleural surface area
38. Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury
39. Spinal cord contusion in the rat: Morphometric analyses of alterations in the spinal cord
40. Correlative analyses of lesion development and functional status after graded spinal cord contusive injuries in the rat
41. A new method of quantifying the extent of tissue loss following spinal cord injury in the rat
42. Long-term effects of methylprednisolone following transection of adult rat spinal cord
43. Cyclosporin A (CsA) treatment following spinal cord injury to the rat: Behavioral effects and stereological assessment of tissue sparing
44. Basic fibroblast growth factor (bFGF) enhances tissue sparing and functional recovery following moderate spinal cord injury
45. Basic fibroblast growth factor (bFGF) enhances functional recovery following severe spinal cord injury to the rat
46. Spinal cord blood flow and evoked potential responses after treatment with nimodipine or methylprednisolone in spinal cord-injured rats
47. Effect of nimodipine or methylprednisolone on recovery from acute experimental spinal cord injury in rats
48. High dose methylprednisolone in the management of acute spinal cord injury - A systematic review from a clinical perspective
49. Spinal cord injury in the rat
50. Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-α production
51. Basic and acidic fibroblast growth factors protect spinal motor neurones in vivo after experimental spinal cord injury
52. Basic fibroblast growth factor increases long-term survival of spinal motor neurons and improves respiratory function after experimental spinal cord injury
53. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX
54. Protective effect of methylprednisolone on vascular injury in rat spinal cord injury
55. Methylprednisolone inhibition of TNF-α expression and NF-κB activation after spinal cord injury in rats
56. Glucocorticoid receptor expression in the spinal cord after traumatic injury in adult rats
57. Therapeutic time window for methylprednisolone in spinal cord injured rat
58. Strategies for the development of new and better pharmacological treatments for acute spinal cord injury
59. Pharmacological therapy of acute spinal cord injury: Studies of high dose methylprednisolone and naloxone